MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Blood Lipid Biomarkers in Early Parkinson Disease and Parkinson Disease with Mild Cognitive Impairment

DX. Deng, LT. Tan (Singapore, Singapore)

Meeting: 2022 International Congress

Abstract Number: 1259

Keywords: Cognitive dysfunction, Lipid metabolism, Parkinson’s

Category: Parkinson's Disease: Cognitive functions

Objective: This study aims to investigate the association between comprehensive blood lipid biomarkers and Parkinson’s disease (PD).

Background: Studies have shown that the serum levels of lipid markers were reduced in PD patients compared to non-PD subjects. Mild cognitive impairment (MCI) is commonly present in PD patients even at the time of diagnosis. It was previously reported that higher triglyceride(TG) level is significant associated with PD-MCI. In view of the potential neuroprotective effects of lipids in PD and limited evidence in this field, we conducted a cross-sectionals study to examine the association between lipids and PD and further explored the relationship between lipids and PD-MCI.

Method: A total of 205 PD patients and 102 non-PD subjects were included from Early Parkinson’s disease Longitudinal Singapore (PALS) cohort. We investigated 6 serum lipid  biomarkers including total cholesterol(TC), triglyceride(TG), high-density lipoprotein cholesterol (HDL-C), apolipoprotein A1(Apo A1), low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B (Apo B).  PD patients were further classified into mild cognitive impairment (MCI) and normal cognition (NC)  subgroups. We conducted a cross-sectionals study to examine the association between lipids and PD and further explored the relationship between lipids and PD-MCI.

Results: PD patients had significantly lower level of lipid panel including TC, TG, HDL-C, Apo A1, LDL-C and Apo B (all p < 0.05).  TC, TG, Apo A1  and  Apo B levels were independent protective factors (p < 0.05) for PD in the logistic regression model. PD-MCI group had significantly higher mean TC, TG levels and  Apo A1 levels compared to  PD-NC group. Higher  TC,  TG and Apo A1 levels were independent risk factors (P < 0.05) for PD-MCI .

Conclusion: We demonstrated that PD patients had significantly lower levels of lipid biomarkers while PD-MCI patients had higher levels of  TC,  TG  and Apo A1.  TC,  TG  and Apo A1 may be useful biomarkers for PD-MCI.

Screenshot 2022-03-15 at 6.44.07 PM

Screenshot 2022-03-15 at 6.44.16 PM

To cite this abstract in AMA style:

DX. Deng, LT. Tan. Blood Lipid Biomarkers in Early Parkinson Disease and Parkinson Disease with Mild Cognitive Impairment [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/blood-lipid-biomarkers-in-early-parkinson-disease-and-parkinson-disease-with-mild-cognitive-impairment/. Accessed July 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/blood-lipid-biomarkers-in-early-parkinson-disease-and-parkinson-disease-with-mild-cognitive-impairment/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley